@article{3106055,
    title = "Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group",
    author = "Bustoros, M. and Kastritis, E. and Sklavenitis-Pistofidis, R. and Liu, C.-J. and Hornburg, K. and Kanellias, N. and Kim, G. and Liu, D. and Gavriatopoulou, M. and Marinac, C.R. and Roussou, M. and Migkou, M. and Noonan, K. and Reyes, K. and Rivotto, B. and Neuse, C.J. and Ziogas, D.C. and Laubach, J. and Terpos, E. and Anderson, K.C. and Richardson, P.G. and Ghobrial, I.M. and Dimopoulos, M.A.",
    journal = "American Journal of Hematology",
    year = "2019",
    volume = "94",
    number = "5",
    pages = "E146-E149",
    publisher = "Wiley-Liss, Inc.",
    issn = "0361-8609, 1096-8652",
    doi = "10.1002/ajh.25441",
    keywords = "M protein, area under the curve;  bone marrow biopsy;  cancer growth;  diagnostic test accuracy study;  follow up;  human;  human tissue;  Letter;  major clinical study;  monoclonal immunoglobulinemia;  multiple myeloma;  priority journal;  protein electrophoresis;  receiver operating characteristic;  risk assessment;  risk factor;  sensitivity and specificity;  biopsy;  bone marrow;  clinical trial;  disease free survival;  monoclonal immunoglobulinemia;  mortality;  multicenter study;  pathology;  smoldering multiple myeloma;  survival rate, Biopsy;  Bone Marrow;  Disease-Free Survival;  Follow-Up Studies;  Humans;  Monoclonal Gammopathy of Undetermined Significance;  Risk Factors;  Smoldering Multiple Myeloma;  Survival Rate"
}